clinical trial · NCT04959240

Expanded Access to Velmanase Alfa

Chiesi Farmaceutici S.p.A.·—·available

Alpha-MannosidosisVelmanase Alfa

brief summary

Individual patient expanded access requests may be considered for patients who have no other treatment options.

started

—

primary completion

—

completion

—

last updated

Sep 25, 2023

Expanded access may provide access for treatment prior to approval by the local regulatory agency.

sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol